Tofacitinib market penetration rate in different clinical fields


Tofacitinib market penetration rate in different clinical fields

MedAnalytics measures Tofacitinib market penetration in different clinical practices. The report is often a source of untapped market potentials that might exist in own brand marketing.

The market penetration of Tofacitinib varied in different clinical practices. In recent year 2019, market penetrations was 8% in Orthopaedic Surgeons, 5% in Internal Medicine Specialists, 4% in Nephrologists, 4% in Endocrinologists, 3% in Diabetologists, 3% in Neurologists, 3% in Gastroenterologists, 3% in Dermatologists, 3% in Physical Medicine Specialists, 3% in Rheumatology Specialists, 2% in Infertility Specialists, 2% in Pediatric Surgeons, 2% in Neurosurgeons, 2% in Colorectal Surgeons, 2% in Psychiatrists, 2% in cancer surgeons, 2% in General & Laparoscopic Surgeons, 2% in Respiratory Medicine Specialists, 2% in Cardiologists, 2% in General Physicians, 1% in Urologists, 1% in Critical Care Medicine Specialists, 1% in ENT Specialists, 1% in Gynecologists & Obstetricians and 1% in Dentists.

For example, market penetration rate of a generic found 10% in dermatology practice. It means, 10% dermatology practitioners are potentials to prescribe this generic. This kind of report is often a source for discovering an untapped market potentials that may exist around in marketing own brand.

Request us for your brand report

Brand report includes - 

  • Present Market share of your brand
  • Current & future performance of your brand
  • Promotional status of your brand
  • Strategic market management of your brand
  • And many more